Page last updated: 2024-08-24

plerixafor and refludan

plerixafor has been researched along with refludan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borkowska, S; Budkowska, M; Dolegowska, B; Ismail, A; Kucia, M; Mierzejewska, K; Ratajczak, J; Ratajczak, MZ; Salata, D; Suszynska, M	1

Other Studies

1 other study(ies) available for plerixafor and refludan

Article	Year
Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs). Leukemia, 2014, Volume: 28, Issue:11 Topics: Animals; Benzylamines; Blood Coagulation; Complement C3; Complement C5a; Cyclams; Female; Fibrinolysis; Fibrinolytic Agents; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Hirudins; Male; Mice, Inbred C57BL; Mice, Knockout; Receptor Cross-Talk; Receptors, CXCR4; Recombinant Proteins; Tranexamic Acid	2014

Article

Year

Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs).

Leukemia, 2014, Volume: 28, Issue:11

Topics: Animals; Benzylamines; Blood Coagulation; Complement C3; Complement C5a; Cyclams; Female; Fibrinolysis; Fibrinolytic Agents; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Hirudins; Male; Mice, Inbred C57BL; Mice, Knockout; Receptor Cross-Talk; Receptors, CXCR4; Recombinant Proteins; Tranexamic Acid

2014